StimLabs® Unveils DermaForm™, a Revolutionary Collagen Wound Care Solution

StimLabs® Launches DermaForm™: A Game-Changer in Wound Management

StimLabs®, a prominent player in the field of regenerative medicine, has made waves with the recent commercial launch of DermaForm™. This innovative product is an FDA 510(k)-cleared, porcine-derived particulate collagen scaffold specifically designed for managing various acute and chronic wounds. As a continuation of its collaboration with Geistlich, DermaForm™ embodies the effort to bring cutting-edge solutions to the medical field.

What is DermaForm™?

DermaForm™ is a unique, engineered collagen scaffold that features a porous structure tailored to support effective wound management and tissue protection. One of the standout features of this product is the specially engineered pore sizes, which facilitate cell infiltration—crucial for the healing process.

The biocompatibility and low immunogenicity of DermaForm™ make it suitable for various wound management applications. The scaffold naturally degrades over time, promoting healing without the complications associated with non-biodegradable materials. Critics of traditional methods often cite issues with coverage and ease of application, and here, DermaForm™ shines with its versatile particulate format.

Versatile Application

The flexibility of DermaForm™ allows it to be applied in multiple ways. Whether used in a dry state or rehydrated, the particulate composition enables healthcare professionals to tailor their approach depending on the specific needs of their patients. This adaptability is particularly beneficial in filling wound voids and covering larger surface areas in cases where primary closure is not feasible.

According to John Daniel, Founder and CEO of StimLabs, “DermaForm represents exactly the kind of differentiated, first-in-class solution that defines StimLabs' approach to building our portfolio.” He emphasized the critical need for effective solutions for large, complex wounds, underscoring that DermaForm™ was created precisely to address these demands.

Practical Benefits for Clinicians

DermaForm™ has been meticulously designed with clinicians in mind. Tom Dion, EVP and Chief Commercial Officer at StimLabs, pointed out key attributes of the product that enhance its practicality in a hospital setting. It is shelf-stable at room temperature, can be poured directly from the vial, and integrates easily into existing workflows without the necessity for complicated preparation processes. These functionalities are expected to facilitate strong adoption rates among hospital wound care teams.

Scientifically Backed Innovation

With a strong scientific foundation, DermaForm™ is the result of extensive research and innovative engineering from Geistlich. Their reputation as a leader in regenerative medicine has provided the backbone for this groundbreaking product. David Wemans, VP of Regenerative Technologies at Geistlich, remarked, “DermaForm is the culmination of deep scientific expertise specifically addressing the challenges faced in complex wound management.”

Conclusion

The introduction of DermaForm™ has the potential to significantly enhance how healthcare professionals manage wounds and can provide effective treatment options for patients grappling with hard-to-heal conditions. This innovative product reflects the commitment of StimLabs and Geistlich to advancing regenerative medicine, aiming for improved patient outcomes through cutting-edge solutions. For more information, refer to the detailed Instructions for Use provided with DermaForm™.

About StimLabs

StimLabs is dedicated to pioneering regenerative medicine, focusing primarily on wound care and surgical applications. With a robust portfolio of products and a commitment to addressing unmet medical needs, StimLabs is a trusted partner for both healthcare professionals and patients.

About Geistlich

Geistlich has been a family-owned company since 1851 and stands as a global leader in regenerative medicine, well-recognized for its contributions to various sectors, including regenerative dentistry. The expertise offered to clinicians through scientific research and educational programs underscores its ongoing dedication to innovation.